Joyce Jackson spent four decades reshaping kidney care in the Pacific Northwest, but her most lasting impact came from recognizing a critical gap: dialysis keeps patients alive, but research offers hope for better solutions. In 2026, the University of Washington Medicine honored Jackson with the Ragen Volunteer Service Award, recognizing how her leadership transformed kidney disease treatment from a management-only challenge into a field driven by discovery.

What Makes the Kidney Research Institute Different?

When Jackson became CEO of Northwest Kidney Centers in 1998, the organization had a proud history as the world's first dialysis provider. However, she recognized that relying on past achievements wasn't enough. "We couldn't just rely on what we had done before," Jackson explained. "We had to think about what comes next." This mindset led to one of her most significant contributions: helping establish the Kidney Research Institute by partnering Northwest Kidney Centers with UW Medicine.

The partnership combined two essential ingredients for medical breakthroughs. Northwest Kidney Centers provided access to patients, clinical insights, and community trust. UW Medicine brought world-class research expertise and infrastructure. Together, they created a pipeline for discovery that continues to advance understanding of kidney disease and improve treatments.

"Research can't happen without patients, and community care is where those patients are," Jackson stated.

Joyce Jackson, Former CEO of Northwest Kidney Centers

How Is the Kidney Research Institute Advancing Treatment Today?

One of the most promising developments emerging from this partnership involves the "kidney on a chip," a credit-card-sized model that uses 3D scaffolding to replicate how a working human kidney functions. Scientists at the Kidney Research Institute are using this technology to study how healthy and diseased kidneys work, test novel drugs, and define the next generation of therapeutic strategies.

This innovation represents a fundamental shift in kidney disease research. For more than 60 years, dialysis has remained the most common treatment for permanent kidney failure. While lifesaving, the technology has changed little over time. Jackson emphasized the urgency of finding new solutions: "We desperately need new answers. Without research, we're not solving the problem, we're just managing it".

Jackson

Steps to Building Effective Health Partnerships

Jackson's approach to advancing kidney care offers lessons for how organizations can collaborate effectively on complex health challenges. Her model demonstrates that progress requires more than good intentions; it demands intentional partnership design and mutual respect.

• Recognize Each Partner's Strengths: Jackson emphasized that successful collaboration requires humility and trust. Each organization must identify what it does best and then build something together that neither could achieve alone.
• Connect Research to Real-World Impact: By linking researchers directly with patients in community care settings, the partnership ensured that scientific work addressed actual clinical needs rather than theoretical questions.
• Invest in Long-Term Infrastructure: Rather than funding isolated projects, Jackson helped establish permanent institutional structures like the Kidney Research Institute that could sustain discovery over decades.

Why Kidney Disease Remains a Critical Health Challenge?

Kidney disease affects millions of Americans and ranks among the most complex and costly challenges in healthcare. Chronic kidney disease (CKD) progresses silently in many patients, and once kidney function declines significantly, treatment options become limited. Dialysis, while essential for survival, requires multiple sessions per week and significantly impacts quality of life.

Jackson's work expanded lifesaving dialysis care across the region, growing Northwest Kidney Centers from seven clinics to 20 during her 21-year tenure as CEO. However, she recognized that expanding access to existing treatments, while important, wasn't enough. The field needed fundamental breakthroughs in understanding kidney disease and developing new therapeutic approaches.

What Happens After Leadership Transitions?

Since retiring from Northwest Kidney Centers in 2019, Jackson has remained deeply engaged with advancing kidney care and research. She helped establish the Bill Peckham Professorship for Person-Centered Care in the UW School of Medicine's Division of Nephrology and continues to support programs that connect research with real-world impact, including efforts that bridge cancer and transplant care.

Her commitment extends far beyond a single organization. Jackson serves on several nonprofit boards, including Bloodworks Northwest, LifeCenter Northwest (the region's organ procurement organization), and Northwest Center, which supports people with disabilities. These roles reflect a lifelong dedication to improving lives at every stage of health and disease.

Jackson describes her approach to service as "joyful service," bringing energy, passion, and purpose to every role she takes on. Yet she is quick to point out that her work has never been done alone. "Every milestone, from expanding care to launching the Kidney Research Institute, was built alongside colleagues, clinicians, researchers, and community partners," she noted.

"Find what you care about, and then contribute in a way that's meaningful to you," Jackson advised.

Joyce Jackson, 2026 Ragen Volunteer Service Award Recipient

For patients living with kidney disease, Jackson's legacy offers an important message: progress depends on people willing to bridge the gap between clinical care and scientific discovery. As kidney disease continues to affect millions, the research infrastructure she helped build offers hope that future treatments will move beyond management toward genuine solutions.